Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
51	[KR] Therapeutic composition for skin regeneration and wound healing using CLASP2 (Registration number 10-1799300)
50	[KR] Oral cleansing composition containing granulocyte macrophage-colony stimulating factor (Registration number 10-1771218)
49	[KR] Method for isolating primary mesenchymal stem cells derived from human embryonic stem cells using cell insert culture system (Registration number 10-1760239)
48	[KR] Method for reprogramming cells using nano-carrier and producing induced pluripotent stem cells (Registration number 10-1751957)
47	[KR] Adherent cells from adipose or placenta tissues and use thereof in therapy (Registration number 10-1738323)
46	[KR] Wound-healing composition for external use and cosmetic composition containing rice cell-derived recombinant human granulocyte macrophage-colony stimulating factor
45	[JP] Method and composition for proliferating of natural killer cell (Registration number 06073417)
44	[KR] Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells (Registration number 10-1662792)
43	[AU] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 2011265956)
42	[KR] Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy (Registration number 10-1557256)